12 results
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... #Metformin #CKD3 ... #CKD4 #Dosing # ... Pharmacology #VisualAbstract
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
and Dosing in CKD ... Dose Initiation ... Prescribing #Dosing #CKD ... #pharmacology # ... algorithm #diabetes
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Dosing #Reduction #Dose ... Anticoagulation #Pharmacology ... #AFib #Renal #CKD
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... patients with T2D, CKD ... and CKD should ... evidence-based pharmacologic ... #Diabetes #CKD #
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... patients with CKD ... Generally, the initial dose ... Purposes Only* #CKD ... #Dosing #Pharmacology
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
Metformin in Diabetic ... until maximum dose ... Initiate at half the dose ... #Metformin #CKD ... #pharmacology #
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... contraindicated in CKD ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
the Total Daily Dose ... (stage IV or V CKD ... including most 2 diabetics ... Weight #Based #pharmacology ... endocrinology #diabetes
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
patients with CKD ... , HF, or diabetes ... #Hyperkalemia #Pharmacology